DNA methylation map in circulating leukocytes mirrors subcutaneous adipose tissue methylation pattern: a genome-wide analysis from non-obese and obese patients

Data de publicació:

Autors de IIS La Fe

Autors aliens a IIS La Fe

  • Crujeiras, AB
  • Diaz-Lagares, A
  • Milagro, FI
  • Navas-Carretero, S
  • Carreira, MC
  • Gomez, A
  • Monteiro, MP
  • Casanueva, FF
  • Esteller, M
  • Martinez, JA

Grups d'Investigació

Abstract

The characterization of the epigenetic changes within the obesity-related adipose tissue will provide new insights to understand this metabolic disorder, but adipose tissue is not easy to sample in population-based studies. We aimed to evaluate the capacity of circulating leukocytes to reflect the adipose tissue-specific DNA methylation status of obesity susceptibility. DNA samples isolated from subcutaneous adipose tissue and circulating leukocytes were hybridized in the Infinium HumanMethylation 450 BeadChip. Data were compared between samples from obese (n = 45) and non-obese (n = 8-10) patients by Wilcoxon-rank test, unadjusted for cell type distributions. A global hypomethylation of the differentially methylated CpG sites (DMCpGs) was observed in the obese subcutaneous adipose tissue and leukocytes. The overlap analysis yielded a number of genes mapped by the common DMCpGs that were identified to reflect the obesity state in the leukocytes. Specifically, the methylation levels of FGFRL1, NCAPH2, PNKD and SMAD3 exhibited excellent and statistically significant efficiencies in the discrimination of obesity from non-obesity status (AUC > 0.80; p < 0.05) and a great correlation between both tissues. Therefore, the current study provided new and valuable DNA methylation biomarkers of obesity-related adipose tissue pathogenesis through peripheral blood analysis, an easily accessible and minimally invasive biological material instead of adipose tissue.

Dades de la publicació

ISSN/ISSNe:
2045-2322, 2045-2322

SCIENTIFIC REPORTS  NATURE PUBLISHING GROUP

Tipus:
Article
Pàgines:
41903-41903
PubMed:
28211912
Factor d'Impacte:
1,533 SCImago
Quartil:
Q1 SCImago

Cites Rebudes en Web of Science: 71

Documents

  • No hi ha documents

Mètriques

Filiacions mostrar / ocultar

Keywords

  • EPIGENETIC MODIFICATIONS; PHYSICAL-ACTIVITY; GASTRIC BYPASS; GENES; ASSOCIATION; EXPRESSION; GROWTH; IDENTIFICATION; INFLAMMATION; METABOLISM

Campos d'Estudi

Projectes associats

RED TEMATICA DE INVESTIGACION COOPERATIVA EN CANCER (RTICC)

Investigador Principal: MIGUEL ÁNGEL SANZ ALONSO

RD12/0036/0014 . INSTITUTO DE SALUD CARLOS III . 2013

IDENTIFICACION DE NUEVAS MOLECULAS CON ACTIVIDAD ANTICOAGULANTE Y/O CITOPROTECTORA EN LA VIA DE LA PROTEINA C: EXPLORANDO SU UTILIDAD CLINICA.

Investigador Principal: SILVIA NAVARRO ROSALES

PI14/00512 . INSTITUTO DE SALUD CARLOS III . 2015

INTEGRATIVE (EPI)GENOMIC AND DRUG TARGET ANALYSIS FOR IDENTIFICATION/VALIDATION OF CLINICALLY VALUABLE BIOMARKERS TO IMPROVE THE POOR OUTCOME OF NON-SMALL CELL LUNG CANCER PATIENTS.

Investigador Principal: JUAN SANDOVAL DEL AMOR

CP13/00055 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2015

ADQUISICIÓN DE UNA PLATAFORMA BIG DATA PARA EL ANÁLISIS Y LA GESTIÓN DE DATOS MULTI-ÓMICOS Y CLÍNICOS ORIENTADA A LA MEDICINA DE PRECISIÓN.

Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL

FUFE15-EE-3906 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2016

IMPLANTACIÓN DE LA MEDICINA PERSONALIZADA EN ONCOLOGÍA PEDIÁTRICA: FARMACOGENÉTICA, EPIGENÉTICA, METABOLÓMICA Y LOS SISTEMAS DE INFORMACIÓN.

Investigador Principal: MARÍA JOSÉ HERRERO CERVERA

MJH-CIS-2016-01 . FUNDACION MUTUA MADRILEÑA . 2016

CARACTERIZACIÓN EPIGENÓMICA DE LA ANOREXIA NERVIOSA. MODELO DE GEMELAS MONOCIGOTAS DISCORDANTES Y VALIDACIÓN EN POBLACIÓN GENERAL.

Investigador Principal: LUIS MIGUEL ROJO MORENO

PI16/01279 . INSTITUTO DE SALUD CARLOS III . 2017

VALIDACIÓN/IDENTIFICACIÓN DE BIOMARCADORES EPIGENÓMICOS PARA DIAGNOSTICO PRECOZ Y RESPUESTA A FÁRMACO PARA MEJORAR EL MALA EVOLUCIÓN DE PACIENTES CON CÁNCER DE PULMÓN CÉLULA NO PEQUEÑA.

Investigador Principal: JUAN SANDOVAL DEL AMOR

PI16/00295 . INSTITUTO DE SALUD CARLOS III . 2017

Compartir la publicació